TABLE 4.
List of mutations that is significantly associated with tumor morphology (compared to no-mutation group)
| Clinical factor | Odds ratio | 95 % CI | P |
|---|---|---|---|
| IDH1 | |||
| Bilobar invasion | 2.75 | 1.17–6.44 | 0.02 |
| KRAS | |||
| R1 margin | 6.51 | 1.63–26.11 | 0.01 |
| Direct involvement of adjacent organ | 10.00 | 1.29–77.51 | 0.03 |
| NRAS | |||
| Intrahepatic metastasis | 6.73 | 1.01–44.68 | 0.05 |
| IDH1 or IDH2 | |||
| Bilobar invasion | 2.72 | 1.24–5.98 | 0.01 |
| NRAS or KRAS | |||
| R1 margin | 5.82 | 1.63–20.81 | 0.01 |
| NRAS, KRAS, or BRAF | |||
| R1 margin | 5.70 | 1.80–18.01 | 0.003 |
CI confidence interval